Sarepta Therapeutics note 1.500% 11/1 shares owned by Citigroup
Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Sarepta Therapeutics note 1.500% 11/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics note 1.500% 11/1 held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.1k | 3.0k | 1.70 |
| 2024-06-30 | $6.4k | 3.0k | 2.15 |
| 2024-03-31 | $1.8k | 1.0k | 1.78 |
| 2023-12-31 | $1.4k | 1.0k | 1.41 |
| 2023-09-30 | $493k | 279k | 1.77 |
| 2023-03-31 | $294k | 152k | 1.93 |
| 2022-12-31 | $999k | 535k | 1.87 |
| 2022-09-30 | $837k | 502k | 1.67 |
| 2021-03-31 | $40k | 31k | 1.29 |
| 2020-12-31 | $25k | 10k | 2.50 |
| 2019-06-30 | $533k | 239k | 2.23 |
| 2019-03-31 | $5.6M | 3.1M | 1.80 |
Top funds holding Sarepta Therapeutics note 1.500% 11/1
View all funds holding Sarepta Therapeutics note 1.500% 11/1